Skip to main content

Obesity

Dosing Chemotherapy in Obese Patients, Still Not Answered
By Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Read More
Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant
Katelyn A. Zink, PharmD, BCOP; Jill Stein, PharmD, BCOP; Patrick Ten Eyck, MS, PhD; Meredith Ginn, PharmD, BCOP
Read More
Comparison of Direct Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Obese or Overweight Patients: A Retrospective Analysis
Jennifer C. Cook, PharmD; Tracy E. Wiczer, BCOP, PharmD; Anthony T. Gerlach, PharmD, FCCM, FCCP; Caitlin Linger, PharmD; Meghan E. Ritchey, PharmD Candidate; Bridgette M. Zickefoose, PharmD; Tzu-Fei Wang, MD; Kristin I. Brower, BCPS, PharmD
Read More

Results 1 - 3 of 3